ログイン
言語:

WEKO3

  • トップ
  • ランキング
To
lat lon distance
To

Field does not validate



インデックスリンク

インデックスツリー

メールアドレスを入力してください。

WEKO

One fine body…

WEKO

One fine body…

アイテム

  1. 20 医学系研究科・医学部
  2. 20A 学術誌論文
  3. 20A1 雑誌掲載論文

Novel method for rapid in-situ hybridization of HER2 using non-contact alternating-current electric-field mixing

http://hdl.handle.net/10295/00006266
http://hdl.handle.net/10295/00006266
a37ccf28-0141-4c1f-8c2a-3bf3da67d615
名前 / ファイル ライセンス アクション
iA_2022_92.pdf iA_2022_92.pdf (2.1 MB)
Item type 学術雑誌論文 / Journal Article(1)
公開日 2023-02-25
タイトル
タイトル Novel method for rapid in-situ hybridization of HER2 using non-contact alternating-current electric-field mixing
言語 en
言語
言語 eng
資源タイプ
資源タイプ識別子 http://purl.org/coar/resource_type/c_6501
資源タイプ journal article
アクセス権
アクセス権 open access
アクセス権URI http://purl.org/coar/access_right/c_abf2
作成者 Saito, Yoshitaro

× Saito, Yoshitaro

en Saito, Yoshitaro

Search repository
Imai, Kazuhiro

× Imai, Kazuhiro

en Imai, Kazuhiro

Search repository
Nakamura, Ryuta

× Nakamura, Ryuta

en Nakamura, Ryuta

Search repository
Nanjo, Hiroshi

× Nanjo, Hiroshi

en Nanjo, Hiroshi

Search repository
Terata, Kaori

× Terata, Kaori

en Terata, Kaori

Search repository
Konno, Hayato

× Konno, Hayato

en Konno, Hayato

Search repository
Akagami, Yoichi

× Akagami, Yoichi

en Akagami, Yoichi

Search repository
Minamiya, Yoshihiro

× Minamiya, Yoshihiro

en Minamiya, Yoshihiro

Search repository
内容記述
内容記述タイプ Abstract
内容記述 Human epidermal growth factor receptor 2 (HER2)-targeted agents are an effective approach to treating HER2-positive breast cancer patients. However, the lack of survival benefit in HER2-negative patients as well as the toxic effects and high cost of the drugs highlight the need for accurate and prompt assessment of HER2 status. Our aim was to evaluate the clinical utility of a novel rapid dual in-situ hybridization (RISH) method developed to facilitate hybridization. The method takes advantage of the non-contact mixing effect of an alternating current (AC) electric field. One hundred sixty-three specimens were used from patients diagnosed with primary breast cancers identified immunohistochemically as HER2 0/1(+), (2+) or (3+). The specimens were all tested using conventional dual in-situ hybridization (DISH), DISH with an automated slide stainer, and RISH. With RISH the HER2 test was completed within 6 h, as compared to 20-22 h needed for the standard protocol. Although RISH produced results more promptly using smaller amounts of labeled antibody, the staining and accuracy of HER2 status evaluation with RISH was equal to or greater than with DISH. These results suggest RISH could be used as a clinical tool to promptly determine HER2 status.
言語 en
出版タイプ
出版タイプ VoR
出版タイプResource http://purl.org/coar/version/c_970fb48d4fbd8a85
書誌情報 en : SCIENTIFIC REPORTS

巻 6, 発行日 2016
収録物識別子
収録物識別子タイプ ISSN
収録物識別子 2045-2322
出版者
出版者 Nature Research
言語 en
関連情報
関連タイプ isIdenticalTo
識別子タイプ DOI
関連識別子 https://doi.org/10.1038/srep30034
権利情報
権利情報 This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
戻る
0
views
See details
Views

Versions

Ver.1 2023-07-25 10:39:13.374787
Show All versions

Share

Mendeley Twitter Facebook Print Addthis

Cite as

エクスポート

OAI-PMH
  • OAI-PMH JPCOAR 2.0
  • OAI-PMH JPCOAR 1.0
  • OAI-PMH DublinCore
  • OAI-PMH DDI
Other Formats
  • JSON
  • BIBTEX

Confirm


Powered by WEKO3


Powered by WEKO3